Background Last year, the authors and other BRG professionals discussed how pharmaceutical manufacturers needed to assess the financial impacts and potential impact scenarios on each drug-pricing provision of the Inflation Reduction Act (IRA). The IRA has and will continue to have a significant impact on the pharmaceutical industry.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Bryan
Contact Bryan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack